Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GSK compared with BMY: revenue, margins and what each company keeps, and the suppliers and customers both name
GSK
GSK plc
Change
Mkt cap
Revenue
Revenue
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
GSK
GSK plc
vs
BMY
Bristol Myers Squibb Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
GSK
No earnings history for GSK.
BMY
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.6%
▲
+1.35%
×0.39
Q2 FY26
±3.7%
▲
+2.79%
×0.76
Q1 FY26
±4.1%
▲
+5.21%
×1.27
Feb 5 '26
±3.8%
▲
+3.30%
×0.87
= implied
GSK realized, solid
BMY realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
GSK
GSK plc
Change
51.26
▼
−0.55%
Mkt cap
$111.2B
Revenue
—
Revenue
—
BMY
Bristol Myers Squibb Co
Change
62.64
▲
+0.80%
Regular session
Nov 10 '26
Mkt cap
$127.0B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
vs
Compare
Regular session
Nov 10 '26
GSK
GSK plc
vs
BMY
Bristol Myers Squibb Co
51.26
▼
−0.55%
Price
62.64
▲
+0.80%
$111.2B
Mkt cap
$127.0B
—
Revenue
$13.1B
Q3 FY26
—
Revenue
$48.2B
FY25
Change
Change
GSK
51.26
▼
−0.55%
vs
BMY
62.64
▲
+0.80%
Regular session
Nov 10 '26